VYKAFTY Trademark

Trademark Overview

On Thursday, March 3, 2022, a trademark application was filed for VYKAFTY with the United States Patent and Trademark Office. The USPTO has given the VYKAFTY trademark a serial number of 97293767. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Monday, September 9, 2024. This trademark is owned by Vertex Pharmaceuticals Incorporated. The VYKAFTY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cystic fibrosis
vykafty

General Information

Serial Number97293767
Word MarkVYKAFTY
Filing DateThursday, March 3, 2022
Status732 - THIRD EXTENSION - GRANTED
Status DateMonday, September 9, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 17, 2023

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cystic fibrosis

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 8, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameVertex Pharmaceuticals Incorporated
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02210
Party NameVertex Pharmaceuticals Incorporated
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02210

Trademark Events

Event DateEvent Description
Monday, March 7, 2022NEW APPLICATION ENTERED
Tuesday, March 8, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, November 30, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 30, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 30, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, November 30, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, December 14, 2022ASSIGNED TO EXAMINER
Wednesday, December 14, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 28, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 17, 2023PUBLISHED FOR OPPOSITION
Tuesday, January 17, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 14, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, September 1, 2023SOU TEAS EXTENSION RECEIVED
Friday, September 1, 2023SOU EXTENSION 1 FILED
Friday, September 1, 2023SOU EXTENSION 1 GRANTED
Tuesday, September 5, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 5, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, March 5, 2024SOU EXTENSION 2 FILED
Tuesday, March 5, 2024SOU EXTENSION 2 GRANTED
Thursday, March 7, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 9, 2024SOU TEAS EXTENSION RECEIVED
Monday, September 9, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 9, 2024SOU EXTENSION 3 GRANTED
Monday, September 9, 2024SOU EXTENSION 3 FILED

Related Keywords

vykafty fibrosis cystic treatment preparations pharmaceutical